The global smart insulin pens market, currently estimated at US$ 3,927.3 million in 2023, is projected to exhibit robust ...

Dr Vincent Simpson aims to reduce plastic waste and save the NHS money by championing reusable insulin pens A doctor and honorary researcher at the University of Exeter is leading a campaign to ...

Switzerland-based CeQur has completed a $120m equity financing round to support the ongoing commercialisation efforts for its ...

Insulin therapy, vital for diabetes management, is often misunderstood. It's not a sign of failure or addiction, nor does it ...

A doctor and honorary researcher at the University of Exeter is leading a campaign to make reusable insulin pens the standard ...

Novo Nordisk has made its smart insulin pens available in the UK, giving people treated within the NHS for diabetes access to devices that can monitor and record dosing information for the first time.

CeQur announced today that it closed a $120 million financing round to support its wearable insulin delivery technology.

Glooko and Hedia announced today that launched their interoperable solution for advanced bolus insulin dosing support.

A law signed in 2023 caps out-of-pocket costs for insulin, asthma inhalers, and epinephrine injectors beginning Jan. 1.